Other

As the 2024 presidential election draws near, there are sharp differences in former President Trump’s and Vice President Harris’ records on health coverage and spending, including the Affordable Care Act, Medicaid, prescription drugs, and more. This 45-minute discussion explores the election’s potential impact on these issues. The discussion addressed questions such as: What are the candidates proposing? What are the pros and cons of the various proposals? What aren’t the candidates talking about? How might the health care policy agenda play out after the election based on who controls the White House and Congress?

This Health Policy 101 chapter explores LGBTQ+ people’s identities and demographics, their experiences with health and health care, including the significant disparities, and the related health policy landscape.

In his latest column, KFF President and CEO Drew Altman describes how Vice President Harris has reframed health as a pocketbook economic issue, which aligns with voters’ concern about health care costs.

In his latest column, KFF President and CEO Drew Altman writes about the fundamentally different world views of the Medicaid program by Republicans and Democrats and how those ideological divides have affected policy proposals, sometimes despite the program’s popularity and broad reach.

This Health Policy 101 chapter explores why polls and surveys are essential for understanding health policy issues and aims to teach you how to evaluate polls effectively. It covers the importance of polls in policy analysis, key considerations for interpretation, polling methodologies, and questions to assess the usefulness of polls. The chapter concludes with real-world examples demonstrating how polling informs policy debates.

The Supreme Court’s June 28 decision overturning the Chevron precedent that required federal courts to defer to reasonable agency decisions when federal law is unclear creates potential challenges for crafting health policy legislation and regulations. On July 25, 2024, a panel of experienced policy and legal experts explored how Congress and federal health agencies are likely to adapt to the Court’s decision and what that may mean for health care policymaking.

In his latest column, KFF President and CEO Drew Altman describes the role of health care in the new presidential election with Vice President Harris facing former President Donald Trump. He discusses how health will likely be a consequential factor in the campaign, with abortion and reproductive rights, along with health care costs, taking center stage.

This analysis uses 2022 data from the American Hospital Association (AHA) Annual Survey Database to present the number and share of hospital workers by occupation who may not be covered by the federal protections against non-compete agreements because they work for a non-profit hospital.

In his latest column, KFF President and CEO Drew Altman unravels the differences between Trump and Biden on Medicare, abortion, drug costs and other health-related issues that KFF’s new side-by-side candidate analysis examines. From the bird’s eye view, these differences amount to a fork in the road in direction on the role of the federal government in health and federal health spending.